A - Agilent Technologies, Inc.

Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, following FDA clearance. This launch underscores Agilent's ongoing commitment to digital pathology, broadening its portfolio to address the increasing demand for high-throughput solutions in clinical laboratories.Pathology laboratories continue to face increasing pressure to improve diagnostic efficiency.

Sep 04, 2026 04:00 AM • businesswire.com

Agilent Introduces the Cary 635 FTIR Spectrometer

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fourier transform infrared (FTIR) analysis. Combining robust engineering, superior performance, and intuitive usability, the Cary 635 FTIR provides laboratories with a powerful solution that enhances reliability, boosts productivity, and delivers the versatility required for today's analytical challe.

Sep 01, 2026 04:00 AM • businesswire.com

INTURAI VENTURES COMPLETES DOMECOMMAND ACQUISITION

INTURAI VENTURES COMPLETES DOMECOMMAND ACQUISITION PR Newswire VANCOUVER, BC, Sept. 1, 2026

Sep 01, 2026 12:00 AM • gurufocus.com

International Markets and Agilent (A): A Deep Dive for Investors

Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Aug 31, 2026 06:16 AM • zacks.com

Agilent Technologies: Q3 Growth, Expanding Margins, And Raised Guidance

Agilent Technologies is upgraded to Buy after a strong Q3 2026, with revenue up 8% and EPS up 18% YoY. All three segments posted robust growth, notably Life Sciences and Diagnostics, which saw operating margin jump nearly 600 bps to 23.5%. Guidance for Q4 and FY26 implies continued momentum, with management projecting 6.5–7.5% revenue growth and 8.5% EPS growth for Q4.

Aug 27, 2026 04:45 AM • seekingalpha.com

Agilent Technologies, Inc. (A) Q3 2026 Earnings Call Transcript

Agilent Technologies, Inc. (A) Q3 2026 Earnings Call Transcript

Aug 26, 2026 03:29 PM • seekingalpha.com

Agilent Technologies Q3 Earnings Call Highlights

Agilent Technologies NYSE: A reported third-quarter fiscal 2026 revenue of $1.88 billion, with core revenue growth of 7.3%, exceeding the high end of its guidance range. The company said earnings per share were $1.56 excluding tariff-refund benefits, up 14% from a year earlier and $0.06 above the top of its guided range.

Aug 26, 2026 03:06 PM • marketbeat.com

Agilent (A) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Aug 26, 2026 03:01 PM • zacks.com

Agilent Technologies (A) Q3 Earnings and Revenues Top Estimates

Agilent Technologies (A) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.37 per share a year ago.

Aug 26, 2026 02:21 PM • zacks.com

Agilent raises annual profit forecast on improving lab tools demand

Agilent Technologies raised its annual profit forecast on Wednesday, betting on ​improving demand for its medical tools ‌and equipment used in lab research and drug development.

Aug 26, 2026 12:33 PM • reuters.com

Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up 7.3% core(1) compared with the third quarter of fiscal year 2025. Third-quarter GAAP net income was $362 million, or $1.28 per share. This compares with $336 million, or $1.18 per share, in the third quarter of fiscal year 2025. Non-GAAP net income(3) was $459 million (including a $17 million net.

Aug 26, 2026 12:05 PM • businesswire.com

Agilent Technologies (A) is a Great Momentum Stock: Should You Buy?

Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.

Aug 25, 2026 09:01 AM • zacks.com

11,685 Shares in Agilent Technologies, Inc. $A Acquired by EP Wealth Advisors LLC

EP Wealth Advisors LLC bought a new stake in shares of Agilent Technologies, Inc. (NYSE: A) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 11,685 shares of the medical research company's stock, valued at approximately

Aug 23, 2026 12:29 AM • defenseworld.net

Allworth Financial LP Takes $2.71 Million Position in Agilent Technologies, Inc. $A

Allworth Financial LP purchased a new stake in Agilent Technologies, Inc. (NYSE: A) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 20,420 shares of the medical research company's stock, valued at approximately $2,712,000. A number of other hedge funds and other

Aug 21, 2026 11:07 PM • defenseworld.net

Exploring Analyst Estimates for Agilent (A) Q3 Earnings, Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.

Aug 21, 2026 06:16 AM • zacks.com

Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not Ignore

Agilent Technologies (NYSE:A | A Price Prediction) heads into a pivotal earnings setup for retirement-oriented portfolios, with a company-confirmed Q3 2026 report after the close on Aug.

Aug 21, 2026 06:00 AM • 247wallst.com

Advisors Capital Management LLC Purchases New Position in Agilent Technologies, Inc. $A

Advisors Capital Management LLC purchased a new position in Agilent Technologies, Inc. (NYSE: A) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 62,474 shares of the medical research company's stock, valued at approximately $8,299,000. Several other large investors

Aug 21, 2026 01:35 AM • defenseworld.net

Agilent Technologies, Inc. $A Shares Bought by Bank of New York Mellon Corp

Bank of New York Mellon Corp raised its position in shares of Agilent Technologies, Inc. (NYSE: A) by 87.4% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,233,964 shares of the medical research company's stock after purchasing an additional 2,440,360 shares

Aug 21, 2026 12:23 AM • defenseworld.net

MDT vs. A: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or Agilent Technologies (A). But which of these two stocks presents investors with the better value opportunity right now?

Aug 18, 2026 08:41 AM • zacks.com

BIP Wealth LLC Makes New $834,000 Investment in Agilent Technologies, Inc. $A

BIP Wealth LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE: A) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 6,277 shares of the medical research company's stock, valued at approximately $834,000. Several other institutional investors have also

Aug 15, 2026 01:05 AM • defenseworld.net

Agilent quarterly filing raises questions, says Jefferies

$155.00 (was $151.56)

Jefferies

Sep 02, 2026 09:47 AM • TheFly

Agilent price target raised to $180 from $160 at Wells Fargo

$180.00 (was $157.69)

Wells Fargo

Aug 27, 2026 03:58 PM • TheFly

Agilent price target raised to $175 from $150 at Barclays

$175.00 (was $157.97)

Luke Sergott · Barclays

Aug 27, 2026 11:19 AM • TheFly

Agilent price target raised to $185 from $155 at RBC Capital

$185.00 (was $158.78)

RBC Capital

Aug 27, 2026 08:48 AM • TheFly

Agilent (A) PT Raised to $180 at TD Cowen

$180.00 (was $157.91)

RBC Capital

Aug 27, 2026 08:00 AM • StreetInsider

Agilent price target raised to $172 from $148 at Evercore ISI

$172.00 (was $155.16)

Vijay Kumar · Evercore ISI

Aug 27, 2026 07:48 AM • TheFly

Agilent price target raised to $180 from $155 at Bernstein

$180.00 (was $155.16)

Bernstein

Aug 27, 2026 07:38 AM • TheFly

Agilent price target raised to $175 from $155 at Goldman Sachs

$175.00 (was $155.16)

Evie Koslosky · Goldman Sachs

Aug 27, 2026 07:13 AM • TheFly

Agilent price target raised to $180 from $170 at Stifel

$180.00 (was $155.16)

Daniel Arias · Stifel Nicolaus

Aug 27, 2026 06:44 AM • TheFly

Agilent price target raised to $148 from $144 at Evercore ISI

$148.00 (was $128.34)

Vijay Kumar · Evercore ISI

Jul 06, 2026 08:38 AM • TheFly

Agilent initiated with a Neutral at Piper Sandler

$150.00 (was $131.62)

David Westenberg · Piper Sandler

Jun 11, 2026 05:50 AM • TheFly

Agilent price target lowered to $165 from $180 at HSBC

$165.00 (was $135.04)

Sidharth Sahoo · HSBC

Jun 03, 2026 05:27 AM • TheFly

Agilent price target raised to $155 from $153 at RBC Capital

$155.00 (was $133.50)

RBC Capital

May 28, 2026 08:35 AM • TheFly

Agilent price target raised to $158 from $156 at Baird

$158.00 (was $115.83)

Robert W. Baird

May 28, 2026 06:48 AM • TheFly

Agilent (A) PT Lowered to $160 at Wells Fargo

$160.00 (was $115.83)

Brandon Couillard · Wells Fargo

May 28, 2026 06:22 AM • StreetInsider

Agilent initiated with an Outperform at RBC Capital

$153.00 (was $115.08)

Dan Leonard · RBC Capital

May 26, 2026 04:12 PM • TheFly

Agilent price target raised to $156 from $155 at Baird

$156.00 (was $114.96)

Catherine Ramsey Schulte · Robert W. Baird

May 26, 2026 06:48 AM • TheFly

Agilent price target lowered to $140 from $150 at Barclays

$140.00 (was $117.52)

Luke Sergott · Barclays

Apr 14, 2026 06:41 AM • TheFly

BofA Securities Reiterates Neutral Rating on Agilent (A) following Biocare Medical acquisition announcement

$150.00 (was $114.21)

Fermium Research

Mar 09, 2026 09:27 AM • StreetInsider

Agilent initiated with a Buy at HSBC

$180.00 (was $139.64)

HSBC

Jan 20, 2026 04:55 AM • TheFly